Real-World Treatment Patterns of Nivolumab + Cabozantinib Compared with Other 1L IO Combinations in mRCC
/ Cherrishe Brown-Bickerstaff / Jan Andreasen
Bone Pain as a Key Prognostic Indicator in Castration-Sensitive Prostate Cancer
/ Deniz Tural / Jan Andreasen
Real-Life Data Confirms Avelumab Maintenance Benefits in Metastatic Urothelial Carcinoma
/ Deniz Tural / Jan Andreasen
Efficacy of 1L Treatment Does Not Predict Efficacy of 2L Cabozantinib for Patients with mRCC
/ Martin Zarba / Jan Andreasen